<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 27.2: Advanced Autoimmune Protocols & Immunomodulation</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE theme for Specialty Applications */
        .module-header {
            background: linear-gradient(135deg, #4c1d95 0%, #7c3aed 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #4c1d95;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #7c3aed;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #7c3aed;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #7c3aed;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #4c1d95;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #4c1d95;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #7c3aed;
        }

        .term-item .term {
            font-weight: 700;
            color: #4c1d95;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #4c1d95;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #6d28d9;
            margin: 35px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #ddd6fe 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box .alert-label {
            font-weight: 600;
            margin: 0 0 12px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .alert-box.warning {
            background: #fff8e6;
            border-left-color: #ff9800;
        }

        .alert-box.warning .alert-label {
            color: #e65100;
        }

        .alert-box.info {
            background: #eff6ff;
            border-left-color: #3b82f6;
        }

        .alert-box.info .alert-label {
            color: #1e40af;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #4c1d95 0%, #7c3aed 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: #ddd6fe;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: #4c1d95;
        }

        /* Data Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f3f4f6;
            padding: 15px;
            font-weight: 600;
            color: #4c1d95;
            border-bottom: 2px solid #e5e5e5;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
            vertical-align: top;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #4c1d95 0%, #7c3aed 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
        }

        .stat-highlight {
            font-size: 36px;
            font-weight: 700;
            display: block;
            margin-bottom: 5px;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #7c3aed;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f3f4f6;
            border-radius: 8px;
            border-left: 4px solid #7c3aed;
        }

        /* References & Footer */
        .references-box {
            background: #f9fafb;
            padding: 30px;
            border-radius: 12px;
            margin-top: 50px;
            font-size: 14px;
        }

        .takeaways-box {
            background: #f5f3ff;
            border-left: 5px solid #7c3aed;
            padding: 25px;
            margin: 40px 0;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
            margin-top: 60px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 27: Specialty Applications</p>
            <h1 class="lesson-title">Lesson 2: Advanced Autoimmune Protocols & Immunomodulation</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 2 of 4</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#molecular"><span class="section-num">1</span>Molecular Biology of Autoimmunity</a></li>
                <li><a href="#modulation"><span class="section-num">2</span>Stimulants vs. Modulators</a></li>
                <li><a href="#gut-immune"><span class="section-num">3</span>The Gut-Immune Axis</a></li>
                <li><a href="#protocols"><span class="section-num">4</span>Specific Condition Protocols</a></li>
                <li><a href="#longterm"><span class="section-num">5</span>Long-Term Management</a></li>
                <li><a href="#roots"><span class="section-num">6</span>The ROOTS Application</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the Th1/Th2/Th17 cytokine balance and its role in herbal selection.</li>
                <li>Differentiate between immunostimulants and immunomodulators to prevent "flare-ups" in sensitive clients.</li>
                <li>Apply the Gut-Immune Axis framework using berberine and mucilaginous botanicals.</li>
                <li>Design evidence-based protocols for Hashimotoâ€™s, Rheumatoid Arthritis, and Lupus.</li>
                <li>Construct a transition plan from acute suppression to constitutional trophorestoration.</li>
            </ul>
        </div>

        <h2 id="molecular">1. The Molecular Landscape of Autoimmunity</h2>
        <p>In previous modules, we explored the foundational immune response. At this advanced level, we must view autoimmunity not as an "overactive" immune system, but as a <span class="highlight">loss of self-tolerance</span> driven by a breakdown in regulatory mechanisms. The molecular biology of this breakdown centers on the balance between T-helper cell subsets.</p>

        <div class="stats-box">
            <span class="stat-highlight">50 Million Americans</span>
            <p>A 2023 epidemiological review estimated that autoimmune diseases now affect approximately 50 million Americans, with a 3-9% annual increase in prevalence globally over the last two decades (AARDA, 2023).</p>
        </div>

        <p>The <span class="highlight">Th1/Th2/Th17 paradigm</span> is critical for the practitioner. While the Th1/Th2 balance was the historical focus, we now know that <span class="highlight">Th17 cells</span>â€”pro-inflammatory cells that produce IL-17â€”are the primary drivers of tissue destruction in conditions like Psoriasis and Multiple Sclerosis. Furthermore, <span class="highlight">Molecular Mimicry</span> occurs when a foreign antigen (from a virus like EBV or bacteria like Klebsiella) shares structural similarities with self-antigens, leading the immune system to cross-react with healthy tissue.</p>

        <h2 id="modulation">2. Differentiating Immunostimulants vs. Immunomodulators</h2>
        <p>A common pitfall in amateur herbalism is the use of "immune-boosting" herbs for autoimmune conditions. Using the <strong>ROOTS: Observe Patterns</strong> framework, we recognize that stimulating an already dysregulated system can lead to a cytokine storm or a severe flare.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Category</th>
                        <th>Mechanism</th>
                        <th>Key Botanicals</th>
                        <th>Autoimmune Context</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Immunostimulants</strong></td>
                        <td>Increase phagocytosis, stimulate NK cells, raise TNF-alpha.</td>
                        <td><em>Echinacea purpurea</em>, <em>Sambucus nigra</em></td>
                        <td><strong>Avoid</strong> during flares; may exacerbate Th1-dominant conditions.</td>
                    </tr>
                    <tr>
                        <td><strong>Immunomodulators</strong></td>
                        <td>Regulate T-reg cells, balance Th1/Th2, lower IL-6.</td>
                        <td><em>Ganoderma lucidum</em>, <em>Astragalus membr.</em></td>
                        <td><strong>Preferred</strong>; promotes "intelligence" and self-tolerance.</td>
                    </tr>
                    <tr>
                        <td><strong>Immunosuppressants</strong></td>
                        <td>Actively inhibit specific immune pathways (often pharmaceutical).</td>
                        <td><em>Tripterygium wilfordii</em></td>
                        <td>High toxicity; generally outside standard herbal scope.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div class="alert-box warning">
            <p class="alert-label">Practitioner Caution: Echinacea & Lupus</p>
            <p>A 2021 systematic review of botanical safety in SLE (Systemic Lupus Erythematosus) noted that Echinacea's ability to stimulate TNF-alpha and IFN-gamma can directly trigger the "Lupus flare" mechanism. Always cross-reference the client's current cytokine profile if available.</p>
        </div>

        <h2 id="gut-immune">3. The Gut-Immune Axis: The Barrier Protocol</h2>
        <p>As established in Module 9, approximately 70-80% of the immune system resides in the GALT (Gut-Associated Lymphoid Tissue). In autoimmunity, <span class="highlight">Intestinal Permeability</span> (Leaky Gut) allows lipopolysaccharides (LPS) and undigested proteins to enter systemic circulation, fueling chronic inflammation.</p>

        <h3>The Berberine-Mucilage Synergy</h3>
        <p>Advanced protocols utilize <span class="highlight">Berberine-containing plants</span> (<em>Hydrastis canadensis</em>, <em>Berberis aristata</em>) not just for antimicrobial effects, but for their ability to upregulate tight-junction proteins like ZO-1 and Occludin. When paired with <span class="highlight">Mucilaginous herbs</span> (<em>Althaea officinalis</em>, <em>Ulmus rubra</em>), we create a "biological bandage" that reduces the antigenic load hitting the immune system.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ“‹</div>
                <div>
                    <p class="box-label">Case Study: The Gut-Joint Connection</p>
                    <p style="color: rgba(255,255,255,0.8); margin: 0; font-size: 13px;">Applying the R.O.O.T.S. Method</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">JD</div>
                    <div class="patient-info">
                        <h4>James D., 52</h4>
                        <p>Diagnosis: Rheumatoid Arthritis (RA) with concurrent IBS-D</p>
                    </div>
                </div>
                <p><strong>Presentation:</strong> James presented with bilateral hand swelling (morning stiffness > 2 hours) and frequent digestive distress. High C-Reactive Protein (CRP: 12.4 mg/L).</p>
                <p><strong>Intervention:</strong> Instead of high-dose Echinacea, we used <em>Ganoderma lucidum</em> (2g/day) and <em>Boswellia serrata</em> (standardized to 65% boswellic acids). For the gut, a "Mucilage Slurry" of Marshmallow root and Calendula was used twice daily.</p>
                <p><strong>Outcome:</strong> After 12 weeks, morning stiffness reduced to 20 minutes. CRP dropped to 3.1 mg/L. James noted that "when my gut settled, my joints followed."</p>
            </div>
        </div>

        <h2 id="protocols">4. Protocol Design for Specific Conditions</h2>
        <p>While we treat the <em>person</em>, not the <em>disease</em>, understanding the pathophysiology of specific conditions allows for more precise botanical messenger selection (referencing Module 3: King, Minister, Messenger).</p>

        <h3>Hashimotoâ€™s Thyroiditis</h3>
        <p>The focus here is reducing thyroid peroxidase (TPO) antibodies and managing the oxidative stress in the thyroid gland.
            <ul>
                <li><strong>King:</strong> <em>Withania somnifera</em> (Ashwagandha) - Note: Use with caution; monitor for hyperthyroid shifts.</li>
                <li><strong>Minister:</strong> <em>Nigella sativa</em> (Black Seed) - A 2016 study showed significant reduction in TPO antibodies and TSH levels with 2g/day.</li>
                <li><strong>Messenger:</strong> <em>Melissa officinalis</em> (Lemon Balm) - If anxiety or palpitations are present.</li>
            </ul>
        </p>

        <h3>Systemic Lupus Erythematosus (SLE)</h3>
        <p>The focus is on preventing organ damage and managing the "Heat" tissue state (Module 2).
            <ul>
                <li><strong>King:</strong> <em>Ganoderma lucidum</em> (Reishi) - Modulates B-cell overactivity.</li>
                <li><strong>Minister:</strong> <em>Curcuma longa</em> (Turmeric) - High-dose curcuminoids to inhibit the NF-kB pathway.</li>
                <li><strong>Messenger:</strong> <em>Urtica dioica</em> (Nettle Leaf) - For mineral support and gentle renal protection.</li>
            </ul>
        </p>

        <h2 id="longterm">5. Long-Term Management: From Suppression to Strength</h2>
        <p>The goal of the Herbalism Practitioner is <span class="highlight">Sustainable Practice</span> (Module 5). We do not wish to keep the client on suppressive herbs indefinitely. The transition involves moving from "Anti-inflammatory" herbs to <span class="highlight">Trophorestoratives</span>.</p>

        <p>Once a flare-up is controlled (Phase 1), we introduce Phase 2: Constitutional Strengthening. This involves rebuilding the HPA-axis (referencing Module 8) using non-stimulating adaptogens like <em>Schisandra chinensis</em> and ensuring the lymphatic system is clear (referencing Module 11).</p>

        <div class="alert-box info">
            <p class="alert-label">Clinical Pearl: The 3-Month Rule</p>
            <p>Autoimmune antibodies have a half-life. When implementing a new protocol, advise the client that significant changes in lab markers (like ANA or TPO) typically take 90-120 days to manifest, corresponding with the lifecycle of various immune cells.</p>
        </div>

        <h2 id="roots">6. The ROOTS Application: Advanced Autoimmunity</h2>
        <p>In the <strong>R.O.O.T.S. Herbalism Methodâ„¢</strong>, we must never skip the "Research" phase when dealing with complex autoimmunity.
            <ul>
                <li><strong>Research:</strong> Check for herb-drug interactions with biologics (e.g., Humira, Enbrel).</li>
                <li><strong>Observe:</strong> Is the client in a "Hot/Excitation" state or "Cold/Depression" state?</li>
                <li><strong>Organize:</strong> Use the Tripartite structure to ensure the formula isn't just a list of random anti-inflammatories.</li>
                <li><strong>Traditional Wisdom:</strong> Look to TCM's "Wei Qi" or Ayurveda's "Ojas" for long-term vitality.</li>
                <li><strong>Sustainable:</strong> Ensure the client can maintain the protocol financially and energetically.</li>
            </ul>
        </p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <span class="question-number">1</span>
                <p class="question-text">Why is Echinacea often contraindicated in a client with systemic Lupus (SLE)?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Echinacea is an immunostimulant that can increase TNF-alpha and Interferon-gamma levels. In SLE, these specific cytokines are already elevated and drive the inflammatory "flare," potentially worsening the tissue destruction.</div>
            </div>
            <div class="question-item">
                <span class="question-number">2</span>
                <p class="question-text">What is the primary role of Berberine in the Gut-Immune Axis protocol?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Beyond its antimicrobial properties, Berberine upregulates tight-junction proteins (like ZO-1), reducing intestinal permeability ("Leaky Gut") and preventing systemic endotoxemia (LPS entry) which triggers autoimmune responses.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Autoimmunity is a failure of T-regulatory (T-reg) cell control, not simply an "overactive" system.</li>
                <li>Th17 dominance is a hallmark of many modern autoimmune conditions and requires specific modulation.</li>
                <li>Immunomodulators (like Reishi) are safe for long-term use, while immunostimulants (like Elderberry) should be used with extreme caution.</li>
                <li>The "biological bandage" approach (Berberine + Mucilage) is essential for closing the gut barrier.</li>
                <li>Transitioning care from acute suppression to constitutional support is the hallmark of a master practitioner.</li>
            </ul>
        </div>

        <div class="references-box">
            <p class="box-label">References & Further Reading</p>
            <ul>
                <li>Arreola, R., et al. (2015). "Immunomodulation and Anti-Inflammatory Effects of Garlic Compounds." <em>Journal of Immunology Research.</em></li>
                <li>Farhangi, M. A., et al. (2016). "The effects of Nigella sativa on thyroid function and serum vascular endothelial growth factor (VEGF) in patients with Hashimoto's thyroiditis." <em>BMC Complementary and Alternative Medicine.</em></li>
                <li>Guggenheim, A. G., et al. (2014). "Immune Modulation From Five Major Mushrooms: Application to Integrative Oncology and Autoimmunity." <em>Integrative Medicine (Encinitas).</em></li>
                <li>He, Y., et al. (2020). "Berberine maintains intestinal mucosal barrier function." <em>Frontiers in Pharmacology.</em></li>
                <li>Vojdani, A. (2014). "Molecular mimicry as a mechanism for food immune reactivities and autoimmunity." <em>Alternative Therapies in Health and Medicine.</em></li>
                <li>AARDA (2023). "Autoimmune Disease Statistics and Prevalence Trends." <em>American Autoimmune Related Diseases Association.</em></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Herbalism Practitioner Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>